INFLUENZA HEMAGGLUTININ CONSTRUCTS AND COMPOSITIONS

The present disclosure relates to influenza hemagglutinin (HA) polypeptides. In some embodiments, the disclosure provides a polypeptide comprising an amino acid sequence with at least 90% sequence identity to any one of SEQ ID NOs:31-33. La présente divulgation concerne des polypeptides d'hémag...

Full description

Saved in:
Bibliographic Details
Main Authors WARFIELD, Kelly Lyn, STONIER, Spencer William, PIERCE, Brian Gregory
Format Patent
LanguageEnglish
French
Published 15.08.2024
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to influenza hemagglutinin (HA) polypeptides. In some embodiments, the disclosure provides a polypeptide comprising an amino acid sequence with at least 90% sequence identity to any one of SEQ ID NOs:31-33. La présente divulgation concerne des polypeptides d'hémagglutinine (HA) de la grippe. Dans certains modes de réalisation, la divulgation concerne un polypeptide comprenant une séquence d'acides aminés ayant au moins 90 % d'identité de séquence avec l'une quelconque des SEQ ID NO : 31-33.
Bibliography:Application Number: WO2024US14481